HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvio Danese Selected Research

Crohn Disease (Crohn's Disease)

11/2022Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
11/2022IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.
10/2022CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
6/2022A phase II, Multicentre, Randomised, Double-Blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Efficacy of Amiselimod in Patients with Moderate to Severe Active Crohn's Disease.
6/2022Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
5/2022Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience.
5/2022Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment Algorithm.
2/2022JAK inhibitors in crohn's disease: ready to go?
1/2022Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
1/2022Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvio Danese Research Topics

Disease

160Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022 - 01/2003
150Ulcerative Colitis
12/2022 - 04/2005
131Crohn Disease (Crohn's Disease)
11/2022 - 04/2005
74Inflammation (Inflammations)
02/2022 - 01/2004
36Neoplasms (Cancer)
01/2022 - 01/2006
33Infections
11/2022 - 01/2011
26Necrosis
01/2022 - 06/2009
24Colitis
01/2021 - 06/2007
14Fistula
01/2022 - 06/2009
12Rheumatoid Arthritis
06/2022 - 06/2014
12COVID-19
05/2022 - 01/2020
9Pathologic Constriction (Stenosis)
01/2022 - 09/2012
9Psoriasis (Pustulosis Palmaris et Plantaris)
01/2022 - 01/2014
9Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 10/2012
7Hemorrhage
12/2022 - 01/2019
7Fibrosis (Cirrhosis)
11/2022 - 11/2019
7Herpes Zoster
06/2022 - 01/2017
6Skin Neoplasms (Skin Cancer)
01/2021 - 01/2017
6Autoimmune Diseases (Autoimmune Disease)
08/2014 - 12/2005
5Abdominal Pain (Pain, Abdominal)
10/2022 - 08/2016
5Thrombosis (Thrombus)
06/2022 - 01/2005
5Psoriatic Arthritis
01/2022 - 07/2014
4Proctitis
11/2022 - 11/2018
4Sepsis (Septicemia)
08/2022 - 02/2010
4Disease Progression
01/2022 - 06/2007
4Anemia
01/2022 - 01/2014
4Arthralgia (Joint Pain)
01/2022 - 12/2019
3Ulcer
11/2022 - 12/2017
3Rheumatic Diseases (Rheumatism)
05/2022 - 06/2020
3Injection Site Reaction
01/2022 - 03/2017
3Nausea
01/2022 - 02/2016
3Diverticulitis
01/2022 - 10/2014
3Opportunistic Infections (Opportunistic Infection)
07/2021 - 10/2016
3Proteinuria
06/2021 - 09/2015
3Sclerosing Cholangitis
11/2020 - 12/2019
3Pneumonia (Pneumonitis)
10/2020 - 06/2012

Drug/Important Bio-Agent (IBA)

48Biological ProductsIBA
12/2022 - 01/2005
46Infliximab (Remicade)FDA Link
06/2022 - 02/2006
38vedolizumabIBA
06/2022 - 08/2013
32Adalimumab (Humira)FDA Link
11/2022 - 06/2009
29Pharmaceutical PreparationsIBA
12/2022 - 01/2008
27Biosimilar PharmaceuticalsIBA
10/2021 - 08/2013
24Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2021 - 04/2005
22CytokinesIBA
01/2020 - 09/2006
21tofacitinibIBA
01/2022 - 05/2013
20Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 01/2008
19Leukocyte L1 Antigen Complex (Calgranulin)IBA
12/2022 - 08/2016
19IntegrinsIBA
07/2022 - 09/2005
18Monoclonal AntibodiesIBA
06/2021 - 01/2007
17Ustekinumab (CNTO 1275)FDA Link
12/2022 - 10/2017
16Biomarkers (Surrogate Marker)IBA
11/2022 - 06/2010
16Tumor Necrosis Factor InhibitorsIBA
05/2021 - 02/2010
15C-Reactive ProteinIBA
12/2022 - 03/2016
15Janus Kinase InhibitorsIBA
06/2022 - 02/2016
12Mesalamine (Mesalazine)FDA LinkGeneric
01/2021 - 10/2010
11SteroidsIBA
06/2021 - 01/2008
10Interleukin-23 (Interleukin 23)IBA
11/2022 - 01/2017
10Dextrans (Dextran)FDA Link
04/2020 - 06/2007
9Interleukin-12 (IL 12)IBA
01/2021 - 11/2010
9Proteins (Proteins, Gene)FDA Link
11/2020 - 07/2006
8Janus KinasesIBA
06/2022 - 01/2015
8Budesonide (Pulmicort)FDA LinkGeneric
11/2019 - 01/2008
7AntibodiesIBA
01/2022 - 01/2005
7upadacitinibIBA
01/2022 - 01/2020
7Immunologic Factors (Immunomodulators)IBA
01/2020 - 02/2010
6Azathioprine (Imuran)FDA LinkGeneric
07/2022 - 09/2010
6CT-P13IBA
01/2021 - 01/2015
6sodium sulfate (sodium bisulfate)FDA LinkGeneric
11/2017 - 07/2008
5InterleukinsIBA
07/2022 - 03/2011
5golimumabFDA Link
01/2021 - 09/2013
5Immunosuppressive Agents (Immunosuppressants)IBA
01/2021 - 10/2010
5LipidsIBA
07/2020 - 11/2015
5AntigensIBA
07/2011 - 01/2004
5CD40 Ligand (CD40L)IBA
03/2011 - 01/2004
4GLPG0634IBA
06/2022 - 08/2017
4ozanimodIBA
01/2022 - 01/2020
4etrolizumabIBA
01/2022 - 12/2014
4Certolizumab PegolFDA Link
01/2021 - 02/2008
4Interleukin-6 (Interleukin 6)IBA
11/2020 - 11/2013
4IronIBA
05/2020 - 01/2014
4SodiumIBA
04/2020 - 06/2007
4Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 03/2012
4Urokinase Plasminogen Activator ReceptorsIBA
10/2016 - 04/2015
4Protein CIBA
12/2011 - 07/2007
3Immunoglobulin G (IgG)IBA
05/2022 - 07/2006
3LigandsIBA
01/2022 - 03/2011
3Phenobarbital (Luminal)FDA Link
01/2022 - 02/2010
3risankizumabIBA
01/2022 - 01/2020
3Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2011
3Peptides (Polypeptides)IBA
12/2021 - 06/2007
3ontamalimabIBA
06/2021 - 01/2017
3CreatinineIBA
06/2021 - 05/2020
3Sphingosine-1-Phosphate ReceptorsIBA
01/2021 - 01/2020

Therapy/Procedure

127Therapeutics
12/2022 - 07/2006
23Biological Therapy
05/2022 - 07/2006
7Remission Induction
11/2019 - 12/2008
5Colectomy
12/2021 - 02/2014
5Drug Therapy (Chemotherapy)
01/2021 - 11/2010
3Precision Medicine
01/2021 - 06/2014
3Aftercare (After-Treatment)
11/2020 - 01/2019